4//SEC Filing
Perry Andrew 4
Accession 0001562180-21-005359
CIK 0001560241other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:53 PM ET
Size
9.1 KB
Accession
0001562180-21-005359
Insider Transaction Report
Form 4
Perry Andrew
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to buy)
2021-08-16+300,000→ 300,000 totalExercise: $14.03Exp: 2031-08-16→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on July 28, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001877793
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:53 PM ET
- Size
- 9.1 KB